On Jan 5, 2022 SalioGen Therapeutics closed a Series B round and raised $115,000,000 from Cystic Fibrosis Foundation, D1 Capital Partners, EPIQ Capital Group, Fidelity […]
Series A – AvengeBio
On Jan 5, 2022 AvengeBio closed a Series A round and raised $45,000,000 from CAM Capital, Longitude Capital, Pappas Capital, Perceptive Advisors, Rock Springs Capital, […]
Post-IPO Debt – Evolva
On Dec 27, 2021 Evolva closed a Post-IPO Debt round and raised CHF12,000,000 from Nice & Green SA, featuring lead investors Nice & Green SA. […]
Post-IPO Equity – BiondVax
On Dec 27, 2021 BiondVax closed a Post-IPO Equity round and raised $9,000,000 from investors, featuring lead investors . About the company: BiondVax is located […]
Series A – VLP Therapeutics
On Dec 27, 2021 VLP Therapeutics closed a Series A round and raised $21,000,000 from Miyako Capital, MUFG Bank, Nobelpharma, Robert Hisaoka, SK Impact Fund, […]
Post-IPO Debt – Evolva
On Dec 27, 2021 Evolva closed a Post-IPO Debt round and raised CHF12,000,000 from Nice & Green SA, featuring lead investors Nice & Green SA. […]
Post-IPO Equity – BiondVax
On Dec 27, 2021 BiondVax closed a Post-IPO Equity round and raised $9,000,000 from investors, featuring lead investors . About the company: BiondVax is located […]
Series A – VLP Therapeutics
On Dec 27, 2021 VLP Therapeutics closed a Series A round and raised $21,000,000 from Miyako Capital, MUFG Bank, Nobelpharma, Robert Hisaoka, SK Impact Fund, […]
Post-IPO Debt – LYSOGENE
On Dec 24, 2021 LYSOGENE closed a Post-IPO Debt round and raised €3,000,000 from European Investment Bank, featuring lead investors European Investment Bank. About the […]
Post-IPO Debt – IMV Inc
On Dec 20, 2021 IMV Inc closed a Post-IPO Debt round and raised $25,000,000 from Horizon Technology Finance, featuring lead investors Horizon Technology Finance. About […]
